Across TCGA pan-cancer cohorts, HIGD1AP3 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of HIGD1AP3’s most consistent transcriptional readouts.
The strongest signal is observed in colon adenocarcinoma (COAD), where HIGD1AP3 RNA is repressed in tumor relative to normal tissue. In most cancer types HIGD1AP3 is over-expressed in tumor, although a few such as COAD show the opposite, repressed pattern.
COAD are the cancer types where HIGD1AP3 tumor–normal differential expression is most reproducible.